Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals

Siafaka, 2015, Chitosan derivatives as effective nanocarriers for ocular release of timolol drug, Int. J. Pharm., 495, 249, 10.1016/j.ijpharm.2015.08.100

Borchard, R.T. (1992). Volume 1: Protein pharmacokinetics and metabolism. Pharmaeutical Biotechnology., Springer Science+Business Media, LLC.

Kassies, 2016, Penetration and delivery characteristics of repetitive microjet injection into the skin, J. Control. Release, 234, 98, 10.1016/j.jconrel.2016.05.019

Rodger, 2000, Drawing up and administering intramuscular injections: A review of the literature, J. Adv. Nurs., 31, 574, 10.1046/j.1365-2648.2000.01312.x

Mishra, 2010, Sciatic nerve injury from intramuscular injection: A persistent and global problem, Int. J. Clin. Pract., 64, 1573, 10.1111/j.1742-1241.2009.02177.x

Nicoll, 2002, Intramuscular injection: An integration research review and guideline for evidence-based practice, Appl. Nurs. Res., 16, 149, 10.1053/apnr.2002.34142

Liang, 2016, Local innate immune responses in the vaccine adjuvant-injected muscle, Clin. Transl. Immunol., 5, 74, 10.1038/cti.2016.19

Herzog, 1997, Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus, Proc. Natl. Acad. Sci. USA, 94, 5804, 10.1073/pnas.94.11.5804

Nanaki, 2017, PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy, Eur. J. Pharm. Sci., 99, 32, 10.1016/j.ejps.2016.12.010

Nanaki, 2017, Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug, Eur. J. Pharm. Biopharm., 117, 77, 10.1016/j.ejpb.2017.03.016

Fletcher, 2018, Sustained delivery of anti-VEGF from injectable hydrogel systems provides a prolonged decrease of endothelial cell proliferation and angiogenesis in vitro, RSC Adv., 8, 8999, 10.1039/C7RA13014G

Moeller, 2008, Alternative routes of administration for systemic delivery of protein pharmaceuticals, Drug Discov. Today Technol., 5, 89, 10.1016/j.ddtec.2008.11.005

Kale, 2014, Needle free injection technology—An overview, Inov. Pharm., 5, 1, 10.24926/iip.v5i1.330

Brown, 2006, Dermal and transdermal drug delivery systems: Current and future prospects, Drug Deliv., 13, 175, 10.1080/10717540500455975

Ranade, 1991, Drug delivery systems. 6. Transdermal drug delivery, J. Clin. Pharmacol., 31, 401, 10.1002/j.1552-4604.1991.tb01895.x

Nerantzaki, 2018, Design of a multifunctional nanoengineered PLLA surface by maximizing the synergies between biochemical and surface design bactericidal effects, ACS Omega, 3, 1509, 10.1021/acsomega.7b01756

Kim, 2018, Nasal vaccine delivery (Chapter fifteen), Appl. Sci. Eng., 1, 1

Lee, 1998, Photomechanical transcutaneous delivery of macromolecules, J. Invest. Dermatol., 111, 925, 10.1046/j.1523-1747.1998.00415.x

Prausnitz, 2008, Transdermal drug delivery, Nat. Biotechnol., 26, 1261, 10.1038/nbt.1504

Chen, 2014, Novel chemical permeation enhancers for transdermal drug delivery, Asian J. Pharm. Sci., 9, 51, 10.1016/j.ajps.2014.01.001

Karande, 2006, Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery, J. Control. Release, 115, 85, 10.1016/j.jconrel.2006.07.001

Finlay, T., Lamb, J., Dougherty, L., and Quinn, C. (2008). Section 2. Practice. Intravenous Therapy in Nursing Practice, Blackwell Publishing.

Maxwell, 2006, Complications of blood transfusion, Contin. Educ. Anaesth. Crit. Care Pain, 6, 225, 10.1093/bjaceaccp/mkl053

Korttila, 1980, Venous complications after intravenous injection of diazepam, flunitrazepam, thiopentone and etomidate, Acta Anaesthesiol. Scand., 24, 227, 10.1111/j.1399-6576.1980.tb01540.x

Awate, 2013, Mechanisms of action of adjuvants, Front. Immunol., 4, 1, 10.3389/fimmu.2013.00114

Harshad, 2010, Recent techniques in nasal drug delivery: A review, Int. J. Drug Dev. Res., 2, 565

Nanaki, S., Tseklima, M., Christodoulou, E., Triantafyllidis, K., Kostoglou, M., and Bikiaris, D.N. (2017). Thiolated chitosan masked polymeric microspheres with incorporated mesocellular silica foam (MCF) for intranasal delivery of paliperidone. Polymers, 9.

Buenestado, 2012, Intranasal drug delivery: An efficient and non-invasive route for systemic administration Focus on opioids, Pharmacol. Ther., 134, 366, 10.1016/j.pharmthera.2012.03.003

Bhise, 2008, Bioavailability of intranasal drug delivery system, Asian J. Pharm., 2, 201, 10.4103/0973-8398.45032

Ramvikas, M., Arumugam, M., Chakrabarti, S.R., and Jaganathan, K.S. (2017). Nasal vaccine delivery (Chapter fifteen). Micro- and Nanotechnology in Vaccine Development, Elsevier Inc.

Bakri, 2018, Overview of intranasally delivered peptides: Key considerations for pharmaceutical development, Expert Opin. Drug Deliv., 15, 991, 10.1080/17425247.2018.1517742

Choi, 2014, The osmotic stress response of split influenza vaccine particles in an acidic environment, Arch. Pahrmacal Res., 37, 1607, 10.1007/s12272-013-0257-5

Banerjee, 2016, Role of nanoparticle size, shape and surface chemistry in oral drug delivery, J. Control. Release, 238, 176, 10.1016/j.jconrel.2016.07.051

Pedro, 2017, Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals, Prog. Mater. Sceince, 89, 306, 10.1016/j.pmatsci.2017.05.001

Hu, 2018, Recent advances of polysaccharide-based nanoparticles for oral insulin delivery, Int. J. Biol. Macromol., 120, 775, 10.1016/j.ijbiomac.2018.08.152

Choi, 2013, A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment, PLoS ONE, 8, 1

Schenk, 2008, The mucosal immune system at the gastrointestinal barrier, Best Pract. Res., 22, 391, 10.1016/j.bpg.2007.11.002

Ensign, 2012, Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers, Adv. Drug Deliv. Rev., 64, 557, 10.1016/j.addr.2011.12.009

Leal, 2017, Physicochemical properties of mucus and their impact on transmucosal drug delivery, Int. J. Pharm., 532, 555, 10.1016/j.ijpharm.2017.09.018

Fievez, 2006, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach, J. Control. Release, 116, 1, 10.1016/j.jconrel.2006.08.013

Brayden, 2005, Intestinal Peyer’s patch M cells and oral vaccine targeting, Drug Discov. Today, 10, 1145, 10.1016/S1359-6446(05)03536-1

Kwon, 2016, Oral delivery of protein drugs bioencapsulated in plant cells, Mol. Ther., 24, 1342, 10.1038/mt.2016.115

Ma, 2018, Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus, Microb. Cell Fact., 17, 1, 10.1186/s12934-018-0861-7

Maharjan, 2016, Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum, Biomaterials, 84, 286, 10.1016/j.biomaterials.2016.01.043

Varum, 2008, Mucoadhesion and the gastrointestinal tract, Crit. Rev. Ther. Drug Carrier Syst., 25, 207, 10.1615/CritRevTherDrugCarrierSyst.v25.i3.10

Dawson, 2004, Transport of polymeric nanoparticle gene carriers in gastric mucus, Biotechnol. Prog., 20, 851, 10.1021/bp0342553

Hounnou, 2002, Anatomical study of the length of the human intestine, Surg. Radiol. Anat., 24, 290, 10.1007/s00276-002-0057-y

Helander, 2014, Surface area of the digestive tract – revisited, Scand. J. Gastroenterol., 49, 681, 10.3109/00365521.2014.898326

Azizi, 2010, Enhancing oral vaccine potency by targeting intestinal M cells, PLoS Pathog., 6, 1001147, 10.1371/journal.ppat.1001147

Mudie, 2010, Physiological parameters for oral delivery and in vitro testing, Mol. Pharm., 7, 1388, 10.1021/mp100149j

Vllasaliu, 2018, Recent advances in oral delivery of biologics: Nanomedicine and physical modes of delivery, Expert Opin. Drug Deliv., 15, 759, 10.1080/17425247.2018.1504017

Tao, 2005, Micromachined devices: The impact of controlled geometry from cell-targeting to bioavailability, J. Control. Release, 109, 127, 10.1016/j.jconrel.2005.09.019

Rzhevskiy, 2018, Microneedles as the technique of drug delivery enhancement in diverse organs and tissues, J. Control. Release, 270, 184, 10.1016/j.jconrel.2017.11.048

Dimmitt, R.A., Sellers, Z.M., and Sibley, E. (2012). XIV-Gastrointestinal system-70 Gastrointestinal tract development. Avery’s Diseases of the Newborn, Elsevier Inc.

Treuting, P.M., Dintzis, S.M., and Montine, K. (2018). Upper gastrointestinal tract. Comparative Anatomy and Histology (Second Edition), A Mouse, Rat, and Human Atlas, Academic Press, Elsevier.

Cheng, 1974, Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine, Am. J. Anat., 141, 481, 10.1002/aja.1001410404

Lennernas, 1998, Human intestinal permeability, Int. J. Pharm. Sci., 87, 403

Podolsky, D.K., Camilleri, M., Shanahan, F., Fitz, J.G., Wang, T.C., and Kalloo, A.N. (2016). Anatomy and development-small intestine: Anatomy and structural anomalies. Yamada’s Atlas of Gastroenterology, Wiley Blackwell.

Dressman, 1990, Upper gastrointestinal (GI) pH in young, healthy men and women, Pharm. Res., 7, 756, 10.1023/A:1015827908309

Rouge, 1996, Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery, Int. J. Pharm., 136, 117, 10.1016/0378-5173(96)85200-8

Moroz, 2016, Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts, Adv. Drug Deliv. Rev., 101, 108, 10.1016/j.addr.2016.01.010

Assaraf, 2016, β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells, Oncotarget, 7, 23322, 10.18632/oncotarget.8019

Huang, 2015, Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine, Biomaterials, 39, 105, 10.1016/j.biomaterials.2014.10.059

Ruiz, 2016, Denaturation and in vitro gastric digestion of heat-treated quinoa protein isolates obtained at various extraction pH, Food Biophys., 11, 184, 10.1007/s11483-016-9429-4

Yamagata, 2006, Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids, J. Control. Release, 112, 343, 10.1016/j.jconrel.2006.03.005

Cerchiara, 2016, Microparticles based on chitosan/carboxymethylcellulose polyelectrolyte complexes for colon delivery of vancomycin, Carbohydr. Polym., 143, 124, 10.1016/j.carbpol.2016.02.020

Bourre, 2011, Intestinal delivery of non-viral gene therapeutics: Physiological barriers and preclinical models, Drug Discov. Today, 16, 203, 10.1016/j.drudis.2011.01.003

Rawlings, 1994, Families of serine peptidases, Methods in Enzymology, Volume 244, 19, 10.1016/0076-6879(94)44004-2

Davies, 2017, Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes a randomized clinical trial, J. Am. Med. Assoc., 318, 1460, 10.1001/jama.2017.14752

Layer, 1986, Fate of pancreatic enzymes aboral transit in humans during small intestinal aboral transit in humans, Am. J. Physiol., 251, 475

Fallingborg, 1989, pH-profile and regional transit fimes of the normal gut measured by a radiotelemetry device, Aliment. Pharmacol. Ther., 3, 605, 10.1111/j.1365-2036.1989.tb00254.x

Bermejo, 2018, PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen, Eur. J. Pharm. Sci., 115, 119, 10.1016/j.ejps.2017.12.009

Valon, 2019, Dying under pressure: Cellular characterisation and in vivo functions of cell death induced by compaction, Biol. Cell, 111, 1, 10.1111/boc.201800075

Chan, 2016, Enhanced mechanical properties in cellulose nanocrystal−poly(oligoethylene glycol methacrylate) injectable nanocomposite hydrogels through control of physical and chemical cross-linking, Biomacromolecules, 17, 649, 10.1021/acs.biomac.5b01598

Yang, 2013, Revealing strong nanocomposite hydrogels reinforced by cellulose nanocrystals: Insight into morphologies and interactions, Appl. Mater. Interfaces, 5, 12960, 10.1021/am403669n

Mert, 2012, A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles, J. Control. Release, 157, 455, 10.1016/j.jconrel.2011.08.032

Liu, 2018, Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery, Int. J. Pharm., 537, 245, 10.1016/j.ijpharm.2017.12.044

Shan, 2015, Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin, ACS Nano, 9, 2345, 10.1021/acsnano.5b00028

Liu, 2016, Efficient mucus permeation and tight junction opening by dissociable “mucus-inert” agent coated trimethyl chitosan nanoparticles for oral insulin delivery, J. Control. Release, 222, 67, 10.1016/j.jconrel.2015.12.008

Leal, 2018, Mucus-penetrating phage-displayed peptides for improved transport across a mucus-like model, Int. J. Pharm., 553, 57, 10.1016/j.ijpharm.2018.09.055

Zhang, 2018, Design and intestinal mucus penetration mechanism of core-shell nanocomplex, J. Control. Release, 272, 29, 10.1016/j.jconrel.2017.12.034

Navarro, 2018, Advances in mucin mimic synthesis and applications in surface science, Curr. Opin. Colloid Interface Sci., 38, 122, 10.1016/j.cocis.2018.09.004

Kufe, 2009, Mucins in cancer: Function, prognosis and therapy Donald, Nat. Rev. Cancer, 9, 874, 10.1038/nrc2761

Atuma, 2001, The adherent gastrointestinal mucus gel layer: Thickness and physical state in vivo, Am. J. Physiol. Liver Physiol., 280, 922

Chassaing, 2019, Identification of inner mucus-associated bacteria by laser capture microdissection, Cell. Mol. Gastroenterol. Hepatol., 7, 157, 10.1016/j.jcmgh.2018.09.009

Bansil, 2018, The biology of mucus: Composition, synthesis and organization, Adv. Drug Deliv. Rev., 124, 3, 10.1016/j.addr.2017.09.023

Boegh, 2015, Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation, Eur. J. Pharm. Biopharm., 95, 136, 10.1016/j.ejpb.2015.01.014

Hansson, 2010, V The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria, Gut Microbes, 1, 51, 10.4161/gmic.1.1.10470

Johansson, 2011, The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions, PNAS, 108, 4659, 10.1073/pnas.1006451107

Bajka, 2015, The influence of small intestinal mucus structure on particle transport ex vivo, Colloids Surf. B Biointerfaces, 135, 73, 10.1016/j.colsurfb.2015.07.038

Li, 2011, Novel mucus-penetrating liposomes as a potential oral drug delivery system: Preparation, in vitro characterization, and enhanced cellular uptake, Int. J. Nanomed., 6, 3151

Cu, 2009, Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus, Mol. Pharm., 6, 173, 10.1021/mp8001254

Muller, 2013, Preparation and characterization of mucus-penetrating papain/poly(acrylic acid) nanoparticles for oral drug delivery applications, J. Nanopart. Res., 15, 1353, 10.1007/s11051-012-1353-z

DeSousa, 2015, Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier, Eur. J. Pharm. Biopharm., 97, 257, 10.1016/j.ejpb.2015.01.008

Moreno, 2018, Development of electrosprayed mucoadhesive chitosan microparticles, Carbohydr. Polym., 190, 240, 10.1016/j.carbpol.2018.02.062

Park, 2017, Nanostructured mucoadhesive microparticles to enhance oral drug bioavailability, J. Ind. Eng. Chem., 54, 262, 10.1016/j.jiec.2017.06.001

Krauland, 2006, Thiolated chitosan microparticles: A vehicle for nasal peptide drug delivery, Int. J. Pharm., 307, 270, 10.1016/j.ijpharm.2005.10.016

Romero, 2016, Development of cationic nanocrystals for ocular delivery, Eur. J. Pharm. Biopharm., 107, 215, 10.1016/j.ejpb.2016.07.005

Paines, 2017, Novel Pemulen/Pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: Evaluation of mucoadhesion and vaginal permeation, Mater. Sci. Eng. C, 79, 886, 10.1016/j.msec.2017.05.030

Kim, 2015, Chitosan-catechol: A polymer with long-lasting mucoadhesive properties, Biomaterials, 52, 161, 10.1016/j.biomaterials.2015.02.010

Ertl, 2000, Lectin-mediated bioadhesion: Preparation, stability and Caco-2 binding of wheat germ agglutinin-functionalized poly(D,L-lactic-co-glycolic acid)-microspheres, J. Drug Target., 8, 173, 10.3109/10611860008996863

Anirudhan, 2018, Novel thiolated chitosan-polyethyleneglycol blend/Montmorillonite composite formulations for the oral delivery of insulin, Bioact. Carbohydr. Diet. Fibre, 16, 22, 10.1016/j.bcdf.2018.02.003

Hornof, 2004, Thiolated chitosans, Eur. J. Pharm. Biopharm., 57, 9, 10.1016/S0939-6411(03)00147-4

Deutel, 2016, In vitro characterization of insulin containing thiomeric microparticles as nasal drug delivery system, Eur. J. Pharm. Sci., 81, 157, 10.1016/j.ejps.2015.10.022

Sajeesh, 2010, Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery, Acta Biomater., 6, 3072, 10.1016/j.actbio.2010.02.007

Farris, 2018, Oral non-viral gene delivery for applications in DNA vaccination and gene therapy, Curr. Opin. Biomed. Eng., 7, 51, 10.1016/j.cobme.2018.09.003

Batista, 2018, Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides, Peptides, 101, 112, 10.1016/j.peptides.2018.01.002

Zhang, 2012, Thiolated Eudragit nanoparticles for oral insulin delivery: Preparation, characterization and in vivo evaluation, Int. J. Pharm., 436, 341, 10.1016/j.ijpharm.2012.06.054

Cone, 2009, Barrier properties of mucus, Adv. Drug Deliv. Rev., 61, 75, 10.1016/j.addr.2008.09.008

Huckaby, 2018, PEGylation for enhancing nanoparticle diffusion in mucus, Adv. Drug Deliv. Rev., 124, 125, 10.1016/j.addr.2017.08.010

Jung, 2000, Biodegradable nanoparticles for oral delivery of peptides: Is there a role for polymers to affect mucosal uptake?, Eur. J. Pharm. Biopharm., 50, 147, 10.1016/S0939-6411(00)00084-9

Lai, 2009, Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues, Adv. Drug Deliv. Rev., 61, 158, 10.1016/j.addr.2008.11.002

Zhaeentana, 2018, The effects of hydrocortisone on tight junction genes in an in vitro model of the human fallopian epithelial cells, Eur. J. Obstet. Gynecol. Reprod. Biol., 229, 127, 10.1016/j.ejogrb.2018.05.034

Bein, 2018, Intestinal tight junctions are severely altered in NEC preterm neonates, Pediatr. Neonatol., 59, 464, 10.1016/j.pedneo.2017.11.018

Gamboa, 2013, In vitro and in vivo models for the study of oral delivery of nanoparticles, Adv. Drug Deliv. Rev., 65, 800, 10.1016/j.addr.2013.01.003

Linnankoski, 2010, Paracellular porosity and pore size of the human intestinal epithelium in tissue and cell culture models, J. Pharm. Sci., 99, 2166, 10.1002/jps.21961

Salama, 2006, Tight junction modulation and its relationship to drug delivery, Adv. Drug Deliv. Rev., 58, 15, 10.1016/j.addr.2006.01.003

Kim, 2014, Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: Improved intestinal paracellular absorption and alleviated cardiotoxicity, Int. J. Pharm., 464, 117, 10.1016/j.ijpharm.2014.01.016

Taverner, 2015, Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation, J. Control. Release, 210, 189, 10.1016/j.jconrel.2015.05.270

Almansour, 2018, Mechanistic studies of a cell-permeant peptide designed to enhance myosin light chain phosphorylation in polarized intestinal epithelia, J. Control. Release, 279, 208, 10.1016/j.jconrel.2018.03.033

Banerjee, 2017, Intestinal patch systems for oral drug delivery, Curr. Opin. Pharmacol., 36, 58, 10.1016/j.coph.2017.08.005

Banerjee, 2016, Intestinal mucoadhesive devices for oral delivery of insulin, Bioeng. Transl. Med., 1, 338, 10.1002/btm2.10015

Shen, 2002, Intestinal patches for oral drug delivery, Pharm. Res., 19, 391, 10.1023/A:1015118923204

Toorisaka, 2005, An enteric-coated dry emulsion formulation for oral insulin delivery, J. Control. Release, 107, 91, 10.1016/j.jconrel.2005.05.022

Toorisaka, 2012, Intestinal patches with an immobilized solid-in-oil formulation for oral protein delivery, Acta Biomater., 8, 653, 10.1016/j.actbio.2011.09.023

Lee, 2018, Drug delivery using microneedle patches: Not just for skin, Expert Opin. Drug Deliv., 15, 541, 10.1080/17425247.2018.1471059

Ma, 2014, Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity, Pharm. Res., 31, 2393, 10.1007/s11095-014-1335-1

Traverso, 2015, Microneedles for Drug Delivery via the Gastrointestinal Tract, J. Pharm. Sci., 104, 362, 10.1002/jps.24182

Dabholkar, 2006, Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux, Int. J. Pharm., 315, 148, 10.1016/j.ijpharm.2006.02.018

Yu, 2015, pH- and NIR light-responsive micelles with hyperthermia-triggered tumor penetration and cytoplasm drug release to reverse doxorubicin resistance in breast cancer, Adv. Funct. Mater., 25, 2489, 10.1002/adfm.201404484

Suzuki, 2016, Evaluation of drug penetration with cationic micelles and their penetration mechanism using an in vitro tumor model, Biomaterials, 98, 120, 10.1016/j.biomaterials.2016.04.037

Sosnik, 2015, Polymeric micelles in mucosal drug delivery: Challenges towards clinical translation, Biotechnol. Adv., 33, 1380, 10.1016/j.biotechadv.2015.01.003

Torchilin, 2005, Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate, Adv. Drug Deliv. Rev., 57, 95, 10.1016/j.addr.2004.06.002

Byrne, 2002, Use of commercial porous ceramic particles for sustained drug delivery, Int. J. Pharm., 246, 61, 10.1016/S0378-5173(02)00357-5

Hoffman, 2012, Hydrogels for biomedical applications, Adv. Drug Deliv. Rev., 64, 18, 10.1016/j.addr.2012.09.010

Li, 2016, Designing hydrogels for controlled drug delivery, Nat. Rev. Mater., 1, 1, 10.1038/natrevmats.2016.71

Chai, Q., Jiao, Y., and Yu, X. (2017). Hydrogels for biomedical applications: Their characteristics and the mechanisms behind them. Gels, 3.

Khutoryanskiy, 2015, Biomedical applications of hydrogels: A review of patents and commercial products, Eur. Polym. J., 65, 252, 10.1016/j.eurpolymj.2014.11.024

Klouda, 2015, Thermoresponsive hydrogels in biomedical applications A seven-year update, Eur. J. Pharm. Biopharm., 97, 338, 10.1016/j.ejpb.2015.05.017

Peppas, 1999, Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin, Macromolecules, 32, 6646, 10.1021/ma990541c

Simpson, 2018, Narrowly dispersed, degradable, and scalable poly(oligoethylene glycol methacrylate)-based nanogels via thermal self-assembly, Ind. Eng. Chem. Res., 57, 7495, 10.1021/acs.iecr.8b00793

Choi, 2017, Telodendrimers for physical encapsulation and covalent linking of individual or combined therapeutics, Mol. Pharm., 14, 2607, 10.1021/acs.molpharmaceut.7b00019

DeFrance, 2018, Structured macroporous hydrogels: Progress, challenges, and opportunities, Adv. Healthc. Mater., 7, 1

Annabi, 2010, Controlling the porosity and microarchitecture of hydrogels for tissue engineering, Tissue Eng. Part B, 16, 371, 10.1089/ten.teb.2009.0639

Kim, 2004, Structure and properties of silk hydrogels, Biomacromolecules, 5, 786, 10.1021/bm0345460

Yokoyama, 1986, Morphology and structure of highly elastic poly(vinyl alcohol) hydrogel prepared by repeated freezing-and-melting, Colloid Polym. Sci., 601, 595, 10.1007/BF01412597

Hermansson, 1981, Characterization of protein gels by scanning and transmission electron microscopy, J. Colloid Interface Sci., 81, 510, 10.1016/0021-9797(81)90433-1

Jeong, 2005, Polymer hollow particles with controllable holes in their surfaces, Nat. Mater., 4, 671, 10.1038/nmat1448

Staruch, 2017, Injectable pore-forming hydrogel scaffolds for complex wound tissue engineering: Designing and controlling their porosity and mechanical properties, Tissue Eng. Part B, 23, 183, 10.1089/ten.teb.2016.0305

Loh, 2013, Three-dimensional scaffolds for tissue engineering applications: Role of porosity and pore size, Tissue Eng. Part B, 19, 485, 10.1089/ten.teb.2012.0437

Li, 2014, Engineering cell alignment in vitro, Biotechnol. Adv., 32, 347, 10.1016/j.biotechadv.2013.11.007

Vlierberghe, 2007, Porous gelatin hydrogels: 1. Cryogenic formation and structure analysis, Biomacromolecules, 8, 331, 10.1021/bm060684o

Lai, 2010, Functional assessment of cross-linked porous gelatin hydrogels for bioengineered cell sheet carriers, Biomacromolecules, 11, 1387, 10.1021/bm100213f

Lewus, 2001, Protein transport in constrained anionic hydrogels: Diffusion and boundary-layer mass transfer, Ind. Eng. Chem. Res., 40, 1548, 10.1021/ie0006054

Pundir, 2013, Sustained release matrix technology and recent advance in matrix drug delivery system: A review, Int. J. Drug Res. Technol., 3, 12

Thedrattanawong, 2018, Controlling the burst release of doxorubicin from polymeric depots via adjusting hydrophobic/hydrophilic properties, J. Drug Deliv. Sci. Technol., 46, 446, 10.1016/j.jddst.2018.06.001

Li, 2017, Liposomes coated with thiolated chitosan as drug carriers of curcumin, Mater. Sci. Eng. C, 80, 156, 10.1016/j.msec.2017.05.136

Martins, 2017, Mucoadhesive properties of thiolated pectin-based pellets prepared by extrusion-spheronization technique, J. Pharm. Sci., 106, 1363, 10.1016/j.xphs.2017.01.028

Lichtenberger, 1995, The hydrophobic barrier properties of gastrointestinal mucus, Annu. Rev. Physiol., 57, 565, 10.1146/annurev.ph.57.030195.003025

Traverso, 2015, Special delivery for the gut, Nature, 519, S19, 10.1038/519S19a

Lam, 2014, Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveries, J. Control. Release, 178, 25, 10.1016/j.jconrel.2013.12.028

Salessiotis, 1972, Measurement of the diameter of the Pylorus in man: Part I. Experimental project for clinical application, Am. J. Surg., 124, 331, 10.1016/0002-9610(72)90036-0

Sultan, 1969, Esophageal diameter and the treatment of achalasia, Am. J. Dig. Dis., 14, 611, 10.1007/BF02239272

Zhang, 2015, A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices, Nat. Mater., 14, 1065, 10.1038/nmat4355

Naraykin, 2018, Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro-resistant microparticles, Eur. J. Pharm. Biopharm., 133, 214, 10.1016/j.ejpb.2018.10.013

Pena, 2017, Alginate microparticles as oral colon drug delivery device: A review, Carbohydr. Polym., 168, 32, 10.1016/j.carbpol.2017.03.033

Chen, 2018, Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue, Colloids Surf. B Biointerfaces, 169, 92, 10.1016/j.colsurfb.2018.05.012

Nadal, 2016, Spray-dried Eudragit® L100 microparticles containing ferulic acid: Formulation, in vitro cytoprotection and in vivo anti-platelet effect, Mater. Sci. Eng. C, 64, 318, 10.1016/j.msec.2016.03.086

Ratzinger, 2010, Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents, Biomaterials, 31, 8716, 10.1016/j.biomaterials.2010.07.095

Koch, B., Rubino, I., Quan, F.-S., Yoo, B., and Choi, H.-J. (2016). Microfabrication for drug delivery. Materials, 9.

Noguchi, 2001, Fusion pathways of vesicles: A Brownian dynamics simulation, J. Chem. Phys., 115, 9547, 10.1063/1.1414314

Pekarek, 1994, Double-walled polymer microspheres for controlled drug release, Nature, 367, 258, 10.1038/367258a0

Zolnik, 2007, Effect of acidic pH on PLGA microsphere degradation and release, J. Control. Release, 122, 338, 10.1016/j.jconrel.2007.05.034

Wong, 2002, Assembly of nanoparticles into hollow spheres using block copolypeptides, Nano Lett., 2, 583, 10.1021/nl020244c

Du, 2009, Advances and challenges in smart and functional polymer vesicles, Soft Matter, 5, 3544, 10.1039/b905635a

Yokoyama, 1989, Molecular design for missile drug: Synthesis of adriamycin conjugated with immunoglobulin G using poly(ethylene glycol)-block-poly(aspartic acid) as intermediate carrier, Die Makromol. Chemie, 190, 2041, 10.1002/macp.1989.021900904

Batycky, 1997, A theoretical model of erosion and macromolecular drug release from biodegrading microspheres, J. Pharm. Sci., 86, 1464, 10.1021/js9604117

Steijn, 2013, Block-and-break generation of microdroplets with fixed volume, Biomicrofluidics, 7, 24108, 10.1063/1.4801637

Abbaspourrad, 2013, Polymer microcapsules with programmable active release, J. Am. Chem. Soc., 135, 7744, 10.1021/ja401960f

Ostafe, 2014, A high-throughput cellulase screening system based on droplet microfluidics, Biomicrofluidics, 8, 041102, 10.1063/1.4886771

Bitar, C., Markwick, K.E., and Hoesli, C.A. (2017, January 3–6). Encapsulation of Pancreatic Islet Cells for Type 1 Diabetes Treatment. Proceedings of the XXV International Conference on Bioencapsulation, Nantes, France. Available online: http://bioencapsulation.net/221_newsletters/Bioencap_innov_2017_11/Bioencap_innov_2017_11.pdf.

Deng, 2014, Reply to the ‘Comment on “Wetting-induced formation of controllable monodisperse multiple emulsions in microfluidics”’ by J. Guzowski and P.; Garstecki, Lab Chip, 2014, 14, DOI:10.1039/ C3LC51229K, Lab Chip, 14, 1479, 10.1039/C4LC00028E

Massenburg, 2016, Clogging in parallelized tapered microfluidic channels, Microfluid. Nanofluidics, 20, 1, 10.1007/s10404-016-1758-6

Wyss, 2006, Mechanism for clogging of microchannels, Phys. Rev. E, 74, 1, 10.1103/PhysRevE.74.061402

Kumar, 2017, Smart microparticles with a pH-responsive macropore for targeted oral drug delivery, Sci. Rep., 7, 061402

Caruso, 2001, Nanoengineering of particle surfaces, Adv. Mater., 13, 11, 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N

Cai, 2013, Porous microsphere and its applications, Int. J. Nanomed., 8, 1111

Ferrari, M., Lee, A., and Lee, J. (2006). Volume I: Biological and biomedical nanotechnology-Microspheres for drug delivery. BioMEMS and Biomedical Nanotechnology, Springer.

Homayun, 2018, Facile fabrication of microparticles with pH-responsive macropores for small intestine targeted drug formulation, Eur. J. Pharm. Biopharm., 128, 316, 10.1016/j.ejpb.2018.05.014

Homayun, 2018, Macropored microparticles with a core–shell architecture for oral delivery of biopharmaceuticals, Arch. Pharm. Res., 41, 848, 10.1007/s12272-018-1062-y

Chen, 2009, Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells, Small, 5, 2673, 10.1002/smll.200900621

Wang, 2015, Mesoporous silica nanoparticles in drug delivery and biomedical applications, Nanomed. Nanotechnol. Biol. Med., 11, 313, 10.1016/j.nano.2014.09.014

Lai, 2003, A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules, J. Am. Chem. Soc., 125, 4451, 10.1021/ja028650l

Chen, 2011, Double mesoporous silica shelled spherical/ellipsoidal nanostructures: Synthesis and hydrophilic/hydrophobic anticancer drug delivery, J. Mater. Chem., 21, 5290, 10.1039/c0jm04024j

Zhao, 2009, Mesoporous silica nanoparticle-based double drug delivery system for glucose responsive controlled release of insulin and cyclic AMP, J. Am. Chem. Soc., 131, 8398, 10.1021/ja901831u

Teo, 2016, Co-delivery of drugs and plasmid DNA for cancer therapy, Adv. Drug Deliv. Rev., 98, 41, 10.1016/j.addr.2015.10.014

Kang, 2011, Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy, Pharm. Res., 28, 3069, 10.1007/s11095-011-0569-4

Cao, 2013, Enhanced antitumor response mediated by the codelivery of paclitaxel and adenoviral vector expressing IL-12, Mol. Pharm., 10, 1804, 10.1021/mp300602j

Mamaeva, 2013, Mesoporous silica nanoparticles in medicine-Recent advances, Adv. Drug Deliv. Rev., 65, 689, 10.1016/j.addr.2012.07.018

Santos, 2018, Halloysite clay nanotubes for life sciences applications: From drug encapsulation to bioscaffold, Adv. Colloid Interface Sci., 257, 58, 10.1016/j.cis.2018.05.007

Slowing, 2008, Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers, Adv. Drug Deliv. Rev., 60, 1278, 10.1016/j.addr.2008.03.012

Kresge, 1992, Ordered mesoporous molecular sieves synthesized by a liquid crystal template mechanism, Nature, 359, 710, 10.1038/359710a0

Inagaki, 1993, Synthesis of highly ordered mesoporous materials from a layered polysilicate, J. Chem. Soc. Chem. Commun., 8, 680, 10.1039/c39930000680

Gaaz, 2015, Properties and applications of polyvinyl alcohol, halloysite nanotubes and their nanocomposites, Molecules, 20, 22833, 10.3390/molecules201219884

Lvov, 2008, Halloysite clay nanotubes for controlled release of protective agents, ACS Nano, 2, 814, 10.1021/nn800259q

Lvov, 2016, The application of halloysite tubule nanoclay in drug delivery, Expert Opin. Drug Deliv., 13, 977, 10.1517/17425247.2016.1169271

Fizir, 2017, Polymer grafted-magnetic halloysite nanotube for controlled and sustained release of cationic drug, J. Colloid Interface Sci., 505, 476, 10.1016/j.jcis.2017.04.011

Lvov, 2016, Halloysite clay nanotubes for loading and sustained release of functional compounds, Adv. Mater., 28, 1227, 10.1002/adma.201502341

Baeza, 2015, Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery, Expert Opin. Drug Deliv., 12, 319, 10.1517/17425247.2014.953051

Croissant, 2016, Protein-gold clusters-capped mesoporous silica nanoparticles for high drug loading, autonomous gemcitabine/doxorubicin co-delivery, and in-vivo tumor imaging, J. Control. Release, 229, 183, 10.1016/j.jconrel.2016.03.030

Chen, 2015, Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging, Biomaterials, 60, 111, 10.1016/j.biomaterials.2015.05.003

Niedermayer, 2015, Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery, Nanoscale, 7, 7953, 10.1039/C4NR07245F

Yao, 2017, Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy, Small, 13, 1, 10.1002/smll.201602225

Lee, 2010, Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics, Angew. Chem. Int. Ed., 49, 8214, 10.1002/anie.201002639

Mekaru, 2015, Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy, Adv. Drug Deliv. Rev., 95, 40, 10.1016/j.addr.2015.09.009

Chen, 2011, Multifunctional magnetically removable nanogated lids of Fe3O4-capped mesoporous silica nanoparticles for intracellular controlled release and MR imaging, Chem. J. Mater., 21, 2535, 10.1039/c0jm02590a

Deshayes, 2015, Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core–shell mesoporous silica nanoparticles, Nanoscale, 7, 13168, 10.1039/C5NR03777H

Gil, 2010, Scale-up methodology for pharmaceutical spray drying, Chem. Today, 28, 18

Ofner, 2017, High-throughput step emulsification for the production of functional materials using a glass microfluidic device, Macromol. Chem. Phys., 218, 1, 10.1002/macp.201600472

Stolovicki, 2018, Throuput enhancement of parallel step emulsifier devices by shear-free and efficient nozzle clearance, Lab Chip, 18, 132, 10.1039/C7LC01037K

Jeong, 2016, Recent developments in scale-up of microfluidic emulsion generation via parallelization, Korean J. Chem. Eng., 33, 1757, 10.1007/s11814-016-0041-6

Holtze, 2013, Large-scale droplet production in microfluidic devices—An industrial perspective, J. Phys. D. Appl. Phys., 46, 1, 10.1088/0022-3727/46/11/114008

Tendulkar, 2012, A three-dimensional microfluidic approach to scaling up microencapsulation of cells, Biomed. Microdevices, 14, 9623, 10.1007/s10544-011-9623-6

Nisisako, 2012, High-volume production of single and compound emulsions in a microfluidic parallelization arrangement coupled with coaxial annular world-to-chip interfaces, Lab Chip, 12, 3426, 10.1039/c2lc40245a

Conchouso, 2014, Three-dimensional parallelization of microfluidic droplet generators for a litre per hour volume production of single emulsions, Lab Chip, 14, 3011, 10.1039/C4LC00379A

Amstad, 2016, Robust scalable high throughput production of monodisperse drops, Lab Chip, 16, 4163, 10.1039/C6LC01075J